AstraZeneca PLC Shares Are Trading Lower After the Company Announced That Datopotamab Deruxtecan Did Not Reach Statistical Significance and Did Not Show an Overall Survival Improvement.
AstraZeneca PLC Shares Are Trading Lower After the Company Announced That Datopotamab Deruxtecan Did Not Reach Statistical Significance and Did Not Show an Overall Survival Improvement.
阿斯利康股份有限公司的股價在該公司宣佈Datopotamab Deruxtecan未達到統計顯著性並未顯示總體生存改善之後下跌。
AstraZeneca PLC Shares Are Trading Lower After the Company Announced That Datopotamab Deruxtecan Did Not Reach Statistical Significance and Did Not Show an Overall Survival Improvement.
阿斯利康公司宣佈Datopotamab Deruxtecan未達到統計學意義,也沒有顯示出總體存活率改善後,該公司股價走低。